XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Equity Compensation and Other Benefit Plans (Tables)
 3 Months Ended
Mar. 31, 2024
Compensation Related Costs [Abstract]  
Schedule of Expenses Related to Equity-Based Compensation
The following table presents the Company’s expenses related to its equity-based compensation instruments for the three months ended March 31, 2024 and 2023:
Three Months Ended
March 31,
(In Thousands)20242023
RSUs$6,243 $3,020 
Total$6,243 $3,020 
Schedule of Expenses Related to Deferred Compensation Plans The following table presents the Company’s expenses related to its Deferred Plans for the three months ended March 31, 2024 and 2023:
 
Three Months Ended
March 31,
(In Thousands)20242023
Non-employee directors$106 $109 
Total$106 $109 
Schedule of Aggregate Income Deferred by Participants and Associated Liability Under Deferred Compensation Plans
The following table presents the aggregate amount of income deferred by participants of the Deferred Plans through March 31, 2024 and December 31, 2023 that had not been distributed and the Company’s associated liability for such deferrals at March 31, 2024 and December 31, 2023:
 
March 31, 2024December 31, 2023
(In Thousands)
Undistributed Income Deferred (1)
 Liability Under Deferred Plans
Undistributed Income Deferred (1)
 Liability Under Deferred Plans
Non-employee directors$2,599 $2,493 $2,611 $2,404 
Total$2,599 $2,493 $2,611 $2,404 
(1)  Represents the cumulative amounts that were deferred by participants through March 31, 2024 and December 31, 2023, which had not been distributed through such respective date.